• Skip to primary navigation
  • Skip to main content

Convergence Healthcare Advisors

Bulge Bracket Expertise, Boutique Bank Environment

  • Home
  • Team
  • Services
  • Experience
  • News
  • Contact
You are here: Home / Archives for Lumora

Lumora

Convergence Healthcare Advises Lumora in its sale to ERBA Diagnostics Mannheim

September 15, 2015 by Convergence Healthcare Advisors

MANNHEIM, Germany--(BUSINESS WIRE)--ERBA Diagnostics Mannheim GmbH, a global in vitro diagnostics company, today announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial markets. Financial terms were not disclosed. The acquisition will see ERBA Diagnostics Mannheim add molecular diagnostics testing to its comprehensive suite of clinical testing products. ERBA Mannheim’s global network of direct sales and distribution, through its group companies in America, Europe, Russia, India and its knowledge of …

[Read more...] about Convergence Healthcare Advises Lumora in its sale to ERBA Diagnostics Mannheim

Convergence Healthcare Advises Lumora in the sale of its Heat Elution technology and IP to Roche

August 24, 2015 by Convergence Healthcare Advisors

PLEASANTON, Calif., Aug. 24, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1 technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, nucleic acid purification technology from specimens including formalin-fixed tissues can be cumbersome and inefficient. Lumora's highly …

[Read more...] about Convergence Healthcare Advises Lumora in the sale of its Heat Elution technology and IP to Roche

The principals of Convergence Healthcare Advisors LLC and Seven Hills Healthcare Advisors LLC are licensed investment banking agents, offering securities through M&A Securities Group, Inc., an unaffiliated broker-dealer. Member FINRA/SIPC. 4151 N. Mulberry Drive, Suite 252 Kansas City, MO 64116.

© 2023 Convergence Healthcare Advisors · Built on the Genesis Framework by AMN Design · Powered by WordPress

Legal Disclosures